https://orcid.org/0000-0002-9374-9701
Citations (40)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Ting Huang, Cheng Lu, Ying Zhang, Bi-yun Lin, Zhe-jun Zhang, Di Zhu, Liang Wang & Yuanzhi Lu. (2023) Effect of activating cancer-associated fibroblasts biomarker TNC on immune cell infiltration and prognosis in breast cancer. Annals of Medicine 55:2.
Read now
Read now
Jiafa Wu, Dongping Luo & Shengnan Li. (2022) Ovo Like Zinc Finger 2 (OVOL2) Suppresses Breast Cancer Stem Cell Traits and Correlates with Immune Cells Infiltration. Breast Cancer: Targets and Therapy 14, pages 211-227.
Read now
Read now
Natsuki Furukawa, Vered Stearns, Cesar A. Santa-Maria & Aleksander S. Popel. (2022) The tumor microenvironment and triple-negative breast cancer aggressiveness: shedding light on mechanisms and targeting. Expert Opinion on Therapeutic Targets 26:12, pages 1041-1056.
Read now
Read now
Ernestina Marianna De Francesco, Francesca Cirillo, Veronica Vella, Antonino Belfiore, Marcello Maggiolini & Rosamaria Lappano. (2022) Triple-negative breast cancer drug resistance, durable efficacy, and cure: how advanced biological insights and emerging drug modalities could transform progress. Expert Opinion on Therapeutic Targets 26:6, pages 513-535.
Read now
Read now
Wanessa Fernanda Altei, Bianca Cruz Pachane, Cristiano Souza, Márcia Maria Chiquitelli Marques & Heloisa Selistre-de-Araújo. (2022) New insights into the discovery of drugs for triple-negative breast cancer metastasis. Expert Opinion on Drug Discovery 17:4, pages 365-376.
Read now
Read now
Articles from other publishers (35)
Roberto Zefferino & Massimo Conese. (2023) A Vaccine against Cancer: Can There Be a Possible Strategy to Face the Challenge? Possible Targets and Paradoxical Effects. Vaccines 11:11, pages 1701.
Crossref
Crossref
Pratikshya Sa, Priyanka Mohapatra, Shasank Sekhar Swain, Auromira Khuntia & Sanjeeb Kumar Sahoo. (2023) Phytochemical-Based Nanomedicine for Targeting Tumor Microenvironment and Inhibiting Cancer Chemoresistance: Recent Advances and Pharmacological Insights. Molecular Pharmaceutics 20:11, pages 5254-5277.
Crossref
Crossref
Shabnam Mohammadi Nour, Nadia Abbasi, Sima Sadi, Navid Ravan, Ali Alipourian, Mahsa Yarizadeh, Asma Soofi, Ali Ataei & Pooya M. Tehrany. (2023)
miRNAs
as key modulators between normal cells and tumor microenvironment interactions
. Chemical Biology & Drug Design 102:4, pages 939-950.
Crossref
Crossref
M. G. Muoio, M. Pellegrino, V. Rapicavoli, M. Talia, G. Scavo, V. Sergi, V. Vella, S. Pettinato, M. G. Galasso, R. Lappano, D. Scordamaglia, F. Cirillo, A. Pulvirenti, D. C. Rigiracciolo, M. Maggiolini, A. Belfiore & E. M. De Francesco. (2023) RAGE inhibition blunts insulin-induced oncogenic signals in breast cancer. Breast Cancer Research 25:1.
Crossref
Crossref
Marianna Talia, Francesca Cirillo, Asia Spinelli, Azzurra Zicarelli, Domenica Scordamaglia, Lucia Muglia, Salvatore De Rosis, Damiano Cosimo Rigiracciolo, Gianfranco Filippelli, Ida Daniela Perrotta, Mariano Davoli, Rosanna De Rosa, Rachele Macirella, Elvira Brunelli, Anna Maria Miglietta, Bruno Nardo, Daniela Tosoni, Salvatore Pece, Ernestina Marianna De Francesco, Antonino Belfiore, Marcello Maggiolini & Rosamaria Lappano. (2023) The Ephrin tyrosine kinase a3 (EphA3) is a novel mediator of RAGE-prompted motility of breast cancer cells. Journal of Experimental & Clinical Cancer Research 42:1.
Crossref
Crossref
Morteza Gholami, Zeynab Nickhah Klashami, Pirooz Ebrahimi, Amir Ali Mahboobipour, Amir Salehi Farid, Aida Vahidi, Marziyeh Zoughi, Mojgan Asadi & Mahsa M. Amoli. (2023) Metformin and long non-coding RNAs in breast cancer. Journal of Translational Medicine 21:1.
Crossref
Crossref
Shaorong Zhao, Teng Pan, Jinhai Deng, Lixia Cao, Jose M. Vicencio, Jingjing Liu, Guanglin Zhou, Tony Ng & Jin Zhang. (2022) Exosomal transfer of miR-181b-5p confers senescence-mediated doxorubicin resistance via modulating BCLAF1 in breast cancer. British Journal of Cancer 128:4, pages 665-677.
Crossref
Crossref
Rosamaria Lappano & Marcello Maggiolini. (2023) Role of the G Protein-Coupled Receptors in Cancer and Stromal Cells: From Functions to Novel Therapeutic Perspectives. Cells 12:4, pages 626.
Crossref
Crossref
Karolina Hanusek, Jakub Karczmarski, Anna Litwiniuk, Katarzyna Urbańska, Filip Ambrozkiewicz, Andrzej Kwiatkowski, Lidia Martyńska, Anita Domańska, Wojciech Bik & Agnieszka Paziewska. (2022) Obesity as a Risk Factor for Breast Cancer—The Role of miRNA. International Journal of Molecular Sciences 23:24, pages 15683.
Crossref
Crossref
Domenica Scordamaglia, Francesca Cirillo, Marianna Talia, Maria Francesca Santolla, Damiano Cosimo Rigiracciolo, Lucia Muglia, Azzurra Zicarelli, Salvatore De Rosis, Francesca Giordano, Anna Maria Miglietta, Ernestina Marianna De Francesco, Veronica Vella, Antonino Belfiore, Rosamaria Lappano & Marcello Maggiolini. (2022) Metformin counteracts stimulatory effects induced by insulin in primary breast cancer cells. Journal of Translational Medicine 20:1.
Crossref
Crossref
Angela Dittmer & Jürgen Dittmer. (2022) A CAF-Fueled TIMP-1/CD63/ITGB1/STAT3 Feedback Loop Promotes Migration and Growth of Breast Cancer Cells. Cancers 14:20, pages 4983.
Crossref
Crossref
Maria Francesca Santolla, Marianna Talia, Francesca Cirillo, Domenica Scordamaglia, Salvatore De Rosis, Asia Spinelli, Anna Maria Miglietta, Bruno Nardo, Gianfranco Filippelli, Ernestina Marianna De Francesco, Antonino Belfiore, Rosamaria Lappano & Marcello Maggiolini. (2022) The AGEs/RAGE Transduction Signaling Prompts IL-8/CXCR1/2-Mediated Interaction between Cancer-Associated Fibroblasts (CAFs) and Breast Cancer Cells. Cells 11:15, pages 2402.
Crossref
Crossref
Youngjoo Kwon. (2022) Potential Pro-Tumorigenic Effect of Bisphenol A in Breast Cancer via Altering the Tumor Microenvironment. Cancers 14:12, pages 3021.
Crossref
Crossref
A. Yu. Goryainova, A. I. Stukan, E. V. Lymar, Z. K. Khachmamuk & I. G. Selezneva. (2022) Induction of ovarian steroidogenesis as an additional potential risk factor for progression in premenopausal patients with hormone-receptor-positive breast cancer receiving tamoxifen as adjuvant therapy. Meditsinskiy sovet = Medical Council:9, pages 131-138.
Crossref
Crossref
Keely Tan & Matthew J. Naylor. (2022) Tumour Microenvironment-Immune Cell Interactions Influencing Breast Cancer Heterogeneity and Disease Progression. Frontiers in Oncology 12.
Crossref
Crossref
Umar Mehraj, Rais A. Ganai, Muzafar A. Macha, Abid Hamid, Mohammed A. Zargar, Ajaz A. Bhat, Mohd Wasim Nasser, Mohammad Haris, Surinder K. Batra, Bader Alshehri, Raid Saleem Al-Baradie, Manzoor A. Mir & Nissar Ahmad Wani. (2021) The tumor microenvironment as driver of stemness and therapeutic resistance in breast cancer: New challenges and therapeutic opportunities. Cellular Oncology 44:6, pages 1209-1229.
Crossref
Crossref
Francesca Cirillo, Michele Pellegrino, Marianna Talia, Ida Daniela Perrotta, Damiano Cosimo Rigiracciolo, Asia Spinelli, Domenica Scordamaglia, Lucia Muglia, Rita Guzzi, Anna Maria Miglietta, Ernestina Marianna De Francesco, Antonino Belfiore, Marcello Maggiolini & Rosamaria Lappano. (2021) Estrogen receptor variant ERα46 and insulin receptor drive in primary breast cancer cells growth effects and interleukin 11 induction prompting the motility of cancer‐associated fibroblasts. Clinical and Translational Medicine 11:11.
Crossref
Crossref
Libo Chen & Ahmed Eleojo Musa. (2021) Boosting immune system against cancer by resveratrol. Phytotherapy Research 35:10, pages 5514-5526.
Crossref
Crossref
David N. Danforth. (2021) The Role of Chronic Inflammation in the Development of Breast Cancer. Cancers 13:15, pages 3918.
Crossref
Crossref
Catarina Nascimento & Fernando Ferreira. (2021) Tumor microenvironment of human breast cancer, and feline mammary carcinoma as a potential study model. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1876:1, pages 188587.
Crossref
Crossref
Chunxiao Sun, Siwei Wang, Yuchen Zhang, Fan Yang, Tianyu Zeng, Fanchen Meng, Mengzhu Yang, Yiqi Yang, Yijia Hua, Ziyi Fu, Jun Li, Xiang Huang, Hao Wu, Yongmei Yin & Wei Li. (2021) Risk Signature of Cancer-Associated Fibroblast–Secreted Cytokines Associates With Clinical Outcomes of Breast Cancer. Frontiers in Oncology 11.
Crossref
Crossref
Fayyaz Ahmed, Muhammad Adnan, Ayesha Malik, Somayya Tariq, Farukh Kamal & Bushra Ijaz. (2021) Perception of breast cancer risk factors: Dysregulation of TGF-β/miRNA axis in Pakistani females. PLOS ONE 16:7, pages e0255243.
Crossref
Crossref
Fanglong Wu, Jin Yang, Junjiang Liu, Ye Wang, Jingtian Mu, Qingxiang Zeng, Shuzhi Deng & Hongmei Zhou. (2021) Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer. Signal Transduction and Targeted Therapy 6:1.
Crossref
Crossref
María Belén Giorello, Francisco Raúl Borzone, Vivian Labovsky, Flavia Valeria Piccioni & Norma Alejandra Chasseing. (2021) Cancer-Associated Fibroblasts in the Breast Tumor Microenvironment. Journal of Mammary Gland Biology and Neoplasia 26:2, pages 135-155.
Crossref
Crossref
Yanjia Yu, Mohan Dai, Wei Xu, Shuangshuang Chen & Qinghua Lu. (2021) Close to Real: Large‐Volume 3D Cell Spheroids on a Superamphiphobic Surface. Advanced Materials Interfaces 8:9.
Crossref
Crossref
Rushikesh S. Joshi, Samanvi S. Kanugula, Sweta Sudhir, Matheus P. Pereira, Saket Jain & Manish K. Aghi. (2021) The Role of Cancer-Associated Fibroblasts in Tumor Progression. Cancers 13:6, pages 1399.
Crossref
Crossref
Robyn V. Broad, Stacey J. Jones, Melina C. Teske, Laura M. Wastall, Andrew M. Hanby, James L. Thorne & Thomas A. Hughes. (2021) Inhibition of interferon-signalling halts cancer-associated fibroblast-dependent protection of breast cancer cells from chemotherapy. British Journal of Cancer 124:6, pages 1110-1120.
Crossref
Crossref
Adele Vivacqua. (2020) GPER1 and microRNA: Two Players in Breast Cancer Progression. International Journal of Molecular Sciences 22:1, pages 98.
Crossref
Crossref
Veronica Vella, Ernestina Marianna De Francesco, Rosamaria Lappano, Maria Grazia Muoio, Livia Manzella, Marcello Maggiolini & Antonino Belfiore. (2020) Microenvironmental Determinants of Breast Cancer Metastasis: Focus on the Crucial Interplay Between Estrogen and Insulin/Insulin-Like Growth Factor Signaling. Frontiers in Cell and Developmental Biology 8.
Crossref
Crossref
Rosamaria Lappano, Marianna Talia, Francesca Cirillo, Damiano Cosimo Rigiracciolo, Domenica Scordamaglia, Rita Guzzi, Anna Maria Miglietta, Ernestina Marianna De Francesco, Antonino Belfiore, Andrew H. Sims & Marcello Maggiolini. (2020) The IL1β-IL1R signaling is involved in the stimulatory effects triggered by hypoxia in breast cancer cells and cancer-associated fibroblasts (CAFs). Journal of Experimental & Clinical Cancer Research 39:1.
Crossref
Crossref
Angela Dittmer & Jürgen Dittmer. (2020) Carcinoma-Associated Fibroblasts Promote Growth of Sox2-Expressing Breast Cancer Cells. Cancers 12:11, pages 3435.
Crossref
Crossref
Xingli Dong, Xupeng Bai, Jie Ni, Hao Zhang, Wei Duan, Peter Graham & Yong Li. (2020) Exosomes and breast cancer drug resistance. Cell Death & Disease 11:11.
Crossref
Crossref
Maria Francesca Santolla & Marcello Maggiolini. (2020) The FGF/FGFR System in Breast Cancer: Oncogenic Features and Therapeutic Perspectives. Cancers 12:10, pages 3029.
Crossref
Crossref
Chengyun Pan, Ping Liu, Dan Ma, Siyu Zhang, Ming Ni, Qin Fang & Jishi Wang. (2020) Bone marrow mesenchymal stem cells in microenvironment transform into cancer-associated fibroblasts to promote the progression of B-cell acute lymphoblastic leukemia. Biomedicine & Pharmacotherapy 130, pages 110610.
Crossref
Crossref
Amarnath Pal, Jennifer C. Ashworth, Pamela Collier, Catherine Probert, Sal Jones, Eduardo Pernaut Leza, Marian L. Meakin, Alison A. Ritchie, David Onion, Philip A Clarke, Cinzia Allegrucci & Anna M. Grabowska. (2020) A 3D Heterotypic Breast Cancer Model Demonstrates a Role for Mesenchymal Stem Cells in Driving a Proliferative and Invasive Phenotype. Cancers 12:8, pages 2290.
Crossref
Crossref